Menthol

薄荷脑

Report date: 2026/03/20 20:03:07
NME

Base Information

Drug NameMenthol
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTransient receptor potential cation channel subfamily M member 8 agonists
TargetsTransient receptor potential cation channel subfamily M member 8
Therapy Area/IndicationsDiagnostic agentsHeat Stress DisordersColonic Polyps +[11] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaTaiwanRussian Federation +[7] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesPt Taisho Pharmaceutical Indonesia TbkStearacl IncThe University Of Edinburgh +[6] 
Inactive CompaniesSandozNihon Pharmaceutical Co LtdNihon Pharmaceutical Co Ltd Osaka Plant +[4] 
Active IndicationsDiagnostic agentsHeat Stress DisordersDry Eye Syndromes +[8] 
Inactive IndicationsColonic PolypsStomach NeoplasmsPharyngitis

Other Information

ATC CodeR05X
Related LinksWikipediaDrugBankKEGG